What are They Saying About the Alleged Health Care and Lost Earnings Cost Estimates

Endocrine Policy Forum
A series of recent economic analyses by Trasande et al. attempts to sound an alarm in both the U.S. and European Union over staggering health care costs and lost earnings estimates associated with diseases allegedly linked to low-level exposure to endocrine disrupting chemicals (EDCs). However, coverage of the studies fails to point out the many obvious flaws with the authors’ economic analysis and underlying assumptions.